Demand is likely to rise as obesity treatment and cardiovascular risk reduction widen the eligible patient pool
That said, Cagrilintide is still in Phase II/III trials
Serious risks that require immediate medical attention (according to the company's safety information): Serious allergic reactions - the company states to stop using the medication immediately and seek emergency care if you experience swelling of face, lips, tongue, or throat, severe rash or itching, rapid heartbeat, difficulty breathing or swallowing, or fainting
For skin brightening, some people notice changes within 2-4 weeks, while more significant improvements may take 8-12 weeks of consistent use
At MedBridge, we support you in tracking your progress and staying consistent with these changes so you can achieve the best possible outcomes
This flexibility is one of the main reasons providers and patients choose compounded semaglutide over brand-name versions